Login
$INM
$19.87 +$1.27 (6.83%) Close

$INM 8-K/A SEC Filings

Filed On Filing
24 Jun 2022 8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule

The below sentence amends and restates the original first sentence under Item 3.01 in its entirety.

22 Dec 2021 8-K/A: Other Events

The accompanying notes are an integral part of these condensed financial statements

16 Nov 2021 8-K/A: Regulation FD Disclosure

On November 10, 2021, InMed Pharmaceuticals Inc. announced financial results for the first quarter of fiscal year 2022 which ended September 30, 2021. The below paragraphs restate the original paragraphs under the subtitle “INM-088 for t...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support